NCT02921009 - McNeel Eye Center Corneal Crosslinking Study | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions

Keratoconus

Interventions

DEVICE

Crosslinking using UV light of two different fluence rates

The treatment of keratoconus involves the application of riboflavin followed by Ultraviolet light of differing intensities. This study will determine the effectiveness of a greater UV light fluence at a shorter treatment time than is currently utilized.

Trial Locations (1)

83713

McNeel Eye Center, Boise

All Listed Sponsors

lead

McNeel Eye Center

INDUSTRY